Target intelligence / Profile preview

Microbial and viral lipid envelope

Molecular classification
Lipid bilayer, Cell membrane, Other
01

Overview

Microbial and viral lipid envelopes are essential structural components that surround many types of bacteria, fungi, and viruses, providing a protective barrier and facilitating interactions with host cells (StatPearls, 2023). In viruses, the envelope is typically derived from the host cell membrane during budding and contains viral glycoproteins necessary for attachment and entry (NIH, 2022). In bacteria and fungi, the lipid bilayer serves as the primary site for energy metabolism and selective transport (PubMed, 2021). Therapeutic strategies targeting these envelopes often involve disrupting the physical integrity of the membrane or inhibiting fusion processes. For example, lipopeptide antibiotics like daptomycin induce membrane depolarization in bacteria, while antiviral agents like docosanol prevent the fusion of viral envelopes with host cell membranes (PubChem, 2024). Because these targets are fundamentally lipid-based, a major challenge in drug development is achieving sufficient selectivity to avoid damaging human cell membranes, which can lead to toxicities such as hemolysis or organ damage (PubMed, 2020).

Other names
Viral envelopeBacterial cytoplasmic membraneMicrobial lipid bilayerCell membranePlasma membrane
02

Mechanism of action

Membrane disruption, pore formation, inhibition of viral-cell fusion, detergent-like solubilization, and sequestration of membrane components.

03

Biological functions

Cellular compartmentalizationViral entrySelective permeabilitySignal transductionProtection
04

Disease associations

InfectionViral infectionBacterial infectionFungal infection
05

Safety considerations

HemolysisNephrotoxicityNeurotoxicityLack of selectivity between microbial and host membranes
06

Interacting drugs

Daptomycin

8 more in the full profile.

07

Biomarkers

Microbial loadViral titerC-reactive proteinProcalcitonin

Beyond the preview

Go deeper on Microbial and viral lipid envelope.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial and viral lipid envelope.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call